Total Liabilities: The total value of all possible claims against the corporation.
Petros Pharmaceuticals, Inc. (PTPI) had Total Liabilities of $2.62M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.99M |
|
-- |
|
-- |
|
$1.03M |
|
$-1.03M |
|
$0.04M |
|
$-0.99M |
|
$-0.99M |
|
$-0.99M |
|
$-0.99M |
|
$-0.99M |
|
$-0.99M |
|
$-1.03M |
|
$-1.03M |
|
46.22M |
|
46.22M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$4.39M |
|
-- |
|
-- |
|
$4.39M |
|
$2.62M |
|
-- |
|
-- |
|
|
Total Liabilities |
$2.62M |
$1.77M |
|
$1.77M |
|
$1.77M |
|
42.37M |
|
| Cash Flow Statement Financials | |
$-0.78M |
|
-- |
|
-- |
|
$5.14M |
|
$4.35M |
|
$-0.78M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-55.72% |
|
-55.72% |
|
-22.46% |
|
-55.72% |
|
$0.04 |
|
$-0.02 |
|
$-0.02 |
|